Global Post Herpetic Neuralgia Treatment Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Post Herpetic Neuralgia Treatment market size will reach 1,953.15 Million USD in 2025 and is projected to reach 2,640.21 Million USD by 2032, with a CAGR of 4.40% (2025-2032). Notably, the China Post Herpetic Neuralgia Treatment market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Post-herpetic neuralgia (PHN) treatment involves addressing the persistent pain that can occur after a shingles (herpes zoster) outbreak. PHN is characterized by chronic pain in the affected nerve pathway, lasting for weeks, months, or even years after the shingles rash has healed. Treatment options for post-herpetic neuralgia aim to manage pain and improve the individual＇s quality of life. Medications such as anticonvulsants, tricyclic antidepressants, and topical agents like lidocaine patches may be prescribed to help alleviate pain. Nerve blocks or injections of corticosteroids can also be considered. Non-pharmacological approaches like physical therapy, transcutaneous electrical nerve stimulation (TENS), and counseling for coping strategies may complement medical interventions. The choice of treatment depends on the severity of the pain, the individual＇s overall health, and their response to specific therapies. Early and comprehensive management is essential to minimize the impact of post-herpetic neuralgia on daily functioning and well-being.
The major global suppliers of Post Herpetic Neuralgia Treatment include Pfizer, Arbor Pharma, Assertio Therapeutics, Teva Pharmaceutical, Teikoku Pharma, Endo Pharma, Mylan, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Post Herpetic Neuralgia Treatment. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Post Herpetic Neuralgia Treatment market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Post Herpetic Neuralgia Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Post Herpetic Neuralgia Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Post Herpetic Neuralgia Treatment Include:
Pfizer
Arbor Pharma
Assertio Therapeutics
Teva Pharmaceutical
Teikoku Pharma
Endo Pharma
Mylan
Hengrui Medicine
Post Herpetic Neuralgia Treatment Product Segment Include:
Anticonvulsants
Skin Patch
Others
Post Herpetic Neuralgia Treatment Product Application Include:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Post Herpetic Neuralgia Treatment Industry PESTEL Analysis
Chapter 3: Global Post Herpetic Neuralgia Treatment Industry Porter's Five Forces Analysis
Chapter 4: Global Post Herpetic Neuralgia Treatment Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Post Herpetic Neuralgia Treatment Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Post Herpetic Neuralgia Treatment Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Post Herpetic Neuralgia Treatment Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Post Herpetic Neuralgia Treatment market size will reach 1,953.15 Million USD in 2025 and is projected to reach 2,640.21 Million USD by 2032, with a CAGR of 4.40% (2025-2032). Notably, the China Post Herpetic Neuralgia Treatment market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Post-herpetic neuralgia (PHN) treatment involves addressing the persistent pain that can occur after a shingles (herpes zoster) outbreak. PHN is characterized by chronic pain in the affected nerve pathway, lasting for weeks, months, or even years after the shingles rash has healed. Treatment options for post-herpetic neuralgia aim to manage pain and improve the individual＇s quality of life. Medications such as anticonvulsants, tricyclic antidepressants, and topical agents like lidocaine patches may be prescribed to help alleviate pain. Nerve blocks or injections of corticosteroids can also be considered. Non-pharmacological approaches like physical therapy, transcutaneous electrical nerve stimulation (TENS), and counseling for coping strategies may complement medical interventions. The choice of treatment depends on the severity of the pain, the individual＇s overall health, and their response to specific therapies. Early and comprehensive management is essential to minimize the impact of post-herpetic neuralgia on daily functioning and well-being.
The major global suppliers of Post Herpetic Neuralgia Treatment include Pfizer, Arbor Pharma, Assertio Therapeutics, Teva Pharmaceutical, Teikoku Pharma, Endo Pharma, Mylan, Hengrui Medicine, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Post Herpetic Neuralgia Treatment. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Post Herpetic Neuralgia Treatment market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Post Herpetic Neuralgia Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Post Herpetic Neuralgia Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Post Herpetic Neuralgia Treatment Include:
Pfizer
Arbor Pharma
Assertio Therapeutics
Teva Pharmaceutical
Teikoku Pharma
Endo Pharma
Mylan
Hengrui Medicine
Post Herpetic Neuralgia Treatment Product Segment Include:
Anticonvulsants
Skin Patch
Others
Post Herpetic Neuralgia Treatment Product Application Include:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Post Herpetic Neuralgia Treatment Industry PESTEL Analysis
Chapter 3: Global Post Herpetic Neuralgia Treatment Industry Porter's Five Forces Analysis
Chapter 4: Global Post Herpetic Neuralgia Treatment Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Post Herpetic Neuralgia Treatment Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Post Herpetic Neuralgia Treatment Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Post Herpetic Neuralgia Treatment Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Post Herpetic Neuralgia Treatment Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Post Herpetic Neuralgia Treatment Product by Type
- 1.2.1 Anticonvulsants
- 1.2.2 Skin Patch
- 1.2.3 Others
- 1.3 Post Herpetic Neuralgia Treatment Product by Application
- 1.3.1 Hospital Pharmacies
- 1.3.2 Online Pharmacies
- 1.3.3 Retail Pharmacies
- 1.4 Global Post Herpetic Neuralgia Treatment Market Size Analysis (2020-2032)
- 1.5 Post Herpetic Neuralgia Treatment Market Development Status and Trends
- 1.5.1 Post Herpetic Neuralgia Treatment Industry Development Status Analysis
- 1.5.2 Post Herpetic Neuralgia Treatment Industry Development Trends Analysis
- 2 Post Herpetic Neuralgia Treatment Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Post Herpetic Neuralgia Treatment Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Post Herpetic Neuralgia Treatment Market Analysis by Country
- 4.1 Global Post Herpetic Neuralgia Treatment Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Post Herpetic Neuralgia Treatment Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Post Herpetic Neuralgia Treatment Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.5 China Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.6 France Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.14 India Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Post Herpetic Neuralgia Treatment Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Post Herpetic Neuralgia Treatment Market Revenue by Key Suppliers (2021-2025)
- 5.2 Post Herpetic Neuralgia Treatment Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Post Herpetic Neuralgia Treatment Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Post Herpetic Neuralgia Treatment Market Analysis by Type
- 6.1 Global Post Herpetic Neuralgia Treatment Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Post Herpetic Neuralgia Treatment Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Pfizer
- 7.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Pfizer Post Herpetic Neuralgia Treatment Product Portfolio
- 7.1.3 Pfizer Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Arbor Pharma
- 7.2.1 Arbor Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Arbor Pharma Post Herpetic Neuralgia Treatment Product Portfolio
- 7.2.3 Arbor Pharma Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Assertio Therapeutics
- 7.3.1 Assertio Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Assertio Therapeutics Post Herpetic Neuralgia Treatment Product Portfolio
- 7.3.3 Assertio Therapeutics Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Teva Pharmaceutical
- 7.4.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Teva Pharmaceutical Post Herpetic Neuralgia Treatment Product Portfolio
- 7.4.3 Teva Pharmaceutical Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Teikoku Pharma
- 7.5.1 Teikoku Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Teikoku Pharma Post Herpetic Neuralgia Treatment Product Portfolio
- 7.5.3 Teikoku Pharma Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Endo Pharma
- 7.6.1 Endo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Endo Pharma Post Herpetic Neuralgia Treatment Product Portfolio
- 7.6.3 Endo Pharma Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Mylan
- 7.7.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Mylan Post Herpetic Neuralgia Treatment Product Portfolio
- 7.7.3 Mylan Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Hengrui Medicine
- 7.8.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Hengrui Medicine Post Herpetic Neuralgia Treatment Product Portfolio
- 7.8.3 Hengrui Medicine Post Herpetic Neuralgia Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Post Herpetic Neuralgia Treatment Industry Chain Analysis
- 8.2 Post Herpetic Neuralgia Treatment Product Downstream Application Analysis
- 8.2.1 Global Post Herpetic Neuralgia Treatment Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Post Herpetic Neuralgia Treatment Revenue and Forecast by Application (2020-2032)
- 8.3 Post Herpetic Neuralgia Treatment Typical Downstream Customers
- 8.4 Post Herpetic Neuralgia Treatment Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
